Szpital Wojewódzki Im. Jana Pawła Ii W Bełchatowie
Bełchatów, Poland
Treatment & access
- Treatments offeredesketamine (Spravato)
- Access routepublic_reimbursed
- Price informationCovered by NFZ (drug programme B.147)
- ReimbursementNFZ drug programme B.147 - leczenie chorych na depresję lekooporną How reimbursement works in Europe →
- Phone+48 44 635 85 55
- Websitehttps://szpital-belchatow.pl/
About this provider
The John Paul II Regional Hospital in Bełchatów (Szpital Wojewódzki im. Jana Pawła II w Bełchatowie) is a large regional hospital that, per NFZ data, provides esketamine for treatment-resistant depression under the fully funded NFZ program B.147. Per its own site, its Psychiatric Department within the Mental Health Centre serves the Bełchatów and Pajęczno counties, treating affective, psychotic and dementia-related disorders with pharmacotherapy, electroconvulsive therapy (including for treatment-resistant depression), psychotherapy, occupational therapy and psychological diagnostics, complemented by an outpatient clinic, a second psychiatric ward and a day ward.
Services & programs
- Psychiatric Department — Mental Health Centre (Centrum Zdrowia Psychicznego) for Bełchatów and Pajęczno counties
- General Psychiatric Department II (admissions from outside the two counties)
- Day psychiatric ward (Oddział Psychiatryczny Dzienny)
- Electroconvulsive therapy, including for severe treatment-resistant depression
- Pharmacotherapy, individual and group psychotherapy, occupational therapy, psychological diagnostics
- Mental health outpatient clinic (Poradnia Zdrowia Psychicznego)
- NFZ drug program B.147 — esketamine for treatment-resistant depression (per NFZ data)
Common questions
How do I access the esketamine program in Bełchatów?
Access is via a psychiatrist's referral. Qualification follows the B.147 criteria: adults 18-75 with moderate to severe treatment-resistant depression after at least two failed antidepressants. Call the hospital exchange at 44 635 85 55 or the psychiatric department secretariat at 44 63 58 547.
What is covered by NFZ?
Everything within the program: esketamine (Spravato) nasal spray, its supervised administration and post-dose observation, for up to 34 weeks. The program is fully NFZ-funded.
How soon can I start?
Per NFZ data (as of June 2026), the first available date was 2026-07-01, with no queue and an average wait of 0 days.
Verification
- License / registryNFZ B.147
- Sourcehttps://api.nfz.gov.pl/app-itl-api/queues?case=1&benefit=LECZENIE%20CHORYCH%20NA%20DEPRESJ%C4%98%20LEKOOPORN%C4%84
- Last verified